An interview with The American Journal of Managed Care about the PAN Challenge grant.
In 2017, an estimated 5.5 million Americans were diagnosed with Alzheimer disease (AD) and 200,000 under 65 years of age are described as having early-onset AD. Even more striking is the finding that 47 million Americans are presymptomatic with stage I AD. These dire statistics beg the question about the merits of getting tested for AD since lifestyle changes can help people at risk, but they are less likely to improve the conditions of those already experiencing cognitive impairment or dementia.
As our country continues its push to lower the cost of healthcare, especially among the burgeoning population of seniors with age-related disabilities, transitioning to a value-based insurance design payment model that rewards value, rather than quantity, will become progressively more important. In the realms of musculoskeletal pain and movement dysfunction, this transition must be accompanied with sincere efforts to identify treatments that can effectively manage pain and reduce the total cost of care.
Patients worldwide are reluctant to visit clinics and hospitals amid fears of COVID-19. Implementing virtual care capabilities can not only relieve the patients of this fear by minimizing in-person exposure and preventing the virus from spreading, but also improve patient-centered care delivery.
Andria Jacobs, RN, MS, CEN, CPHQ, chief operating officer for PCG Software, discusses 3 billing and claims issues facing the health care industry in the wake of the COVID-19 pandemic.
As we approach the January 20 inauguration of Donald J. Trump as the 45th president of the United States, we come to the end of an all-too-brief era of unparalleled government transparency and leadership accessibility: Acting Administrator of CMS Andy Slavitt will be stepping down from his post.
While many questions on the outlook of healthcare “re-reform” remain afloat, many important insights into President Donald Trump’s potential path forward are now identified.
Convincing your chief financial officer to invest in technology that addresses patients’ social determinants of health.
Moving from a comfortable place to one with new paths, new experiences, and new goals is both challenging and invigorating at the same time. Good fortune is when you choose to change because the future belongs to those who adapt.
Results from the first 70 days of the Virta Clinic trial suggest the historic dietary approach to management of type 2 diabetes has been all wrong.
The quality-adjusted life-year (QALY) is a popular tool for value assessment but is flawed. This paper highlights potential solutions.
There's only a month until the application portal closes for the Bundled Payment for Care Improvement Advanced initiative, the first value-based model launched under the Trump administration.
The fiscal year 2020 (FY2020) Inpatient Prospective Payment Systems (IPPS) proposed rule notably includes approximately 1500 complications or comorbidities (CC)/major complications or comorbidities (MCC) designation changes and 324 changes to International Classification of Diseases, Tenth Revision, Clinical Modification codes, along with several other updates. The designation changes are an effort to respond to the notion that the CC/MCC assignment are no longer appropriate as conditions and factors have shifted.
Chronic care management is available under Medicare but has been underused thus far.
How can perioperative mobile apps can increase patient compliance while saving money?
A Samfund grant recipient narrates her experience of being diagnosed young with cancer and how the support from The Samfund "made everyday school and life manageable."
Access and quality are inseparable, so providers prioritizing population health goals can find success by starting from a solid foundation of patient access. So how can providers streamline access to care and directly influence population health? The answer lies with sophisticated patient engagement technology.
Overall, the United States is predicted to see a shortage of 193,000 nursing professionals by 2020, according to a 2015 report.
In this series, we have used the recent announcement by CVS Health regarding a strategy to lower drug prices as an example to review basic pharmacoeconomic principles. For Part 3, we are going to discuss various stakeholders and how each might view the results of decisions based off of pharmacoeconomic analyses.